Table 1—

Outcomes of extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB) cases in Estonia, Germany, Italy and the Russian Federation

Treatment successDiedDefaultFailureTransferredTotal patients completing treatment
XDR-TB#22 (39.3)14 (25.0)8 (14.3)12 (21.4)0 (0.0)56
MDR-TB resistant to all first-line drugs123 (53.7)35 (15.3)39 (17.0)29 (12.7)3 (1.3)229
Other MDR-TB+42 (66.7)8 (12.7)10 (15.9)3 (4.8)0 (0.0)63
Total187 (53.7)57 (16.4)57 (16.4)44 (12.6)3 (0.9)348
  • Data are presented as n (%) or n. #: resistance to at least rifampin and isoniazid (definition of MDR-TB) in addition to any fluoroquinolone, and at least one of the three injectable anti-TB drugs (capreomycin, kanamycin and amikacin); : cases resistant to isoniazid, rifampicin ethambutol, streptomycin and, when tested, pyrazinamide; +: cases susceptible to at least one first-line anti-TB drug. Default and transferred cases included in this table were removed from the analysis presented in the text.